- Sold out
/https://libri-media.knygos-static.lt/47312b1f-425d-4af7-a53c-7ca096ed60f0/2)
- Publisher: Wiley VCH Verlag GmbH
- Year: 2012
- ISBN-10: 3527330739
- ISBN-13: 9783527330737
- Format: 17.7 x 24.9 x 2.7 cm, kieti viršeliai
- Language: English
Analogue-based Drug Discovery 3 (e-book) (used book) | bookbook.eu
Reviews
Description
Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.
- Publisher: Wiley VCH Verlag GmbH
- Year: 2012
- ISBN-10: 3527330739
- ISBN-13: 9783527330737
- Format: 17.7 x 24.9 x 2.7 cm, kieti viršeliai
- Language: English English
Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.
Reviews